Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
02.05.2017 23:38:00

Quest Diagnostics To Speak At The Deutsche Bank 42nd Annual Health Care Conference

MADISON, N.J., May 2, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Deutsche Bank 42nd Annual Health Care Conference in Boston. Mark Guinan, Executive Vice President and CFO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Wednesday, May 3, 2017 at 9:20 a.m. Eastern Time.

The presentation will be webcast live during the conference and will be available to registered investors on the following site: http://edge.media-server.com/m/p/zaz2ofrk and to the public on the company's investor relations page which can be accessed at www.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until June 2, 2017. 

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes.  Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 43,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.

Contacts:
Shawn Bevec (Investors):       973-520-2900
Dennis Moynihan (Media):      973-520-2800    

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-deutsche-bank-42nd-annual-health-care-conference-300450090.html

SOURCE Quest Diagnostics

Analysen zu Quest Diagnostics Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Quest Diagnostics Inc. 157,15 0,80% Quest Diagnostics Inc.